DENTSPLY SIRONA (NASDAQ:XRAY) Issues FY 2025 Earnings Guidance

Key Points

• DENTSPLY SIRONA has provided FY 2025 earnings guidance, projecting EPS of $1.800-$2.000 and revenue of $3.6 billion-$3.7 billion, aligning closely with consensus estimates.
• The company’s stock decreased by 2.6% and has a market capitalization of $2.73 billion, with significant volatility observed over the past year.
• DENTSPLY SIRONA recently announced a quarterly dividend of $0.16 per share, reflecting an annualized yield of 4.7% despite a negative dividend payout ratio.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 1.800-2.000 for the period, compared to the consensus estimate of 1.897. The company issued revenue guidance of $3.6 billion-$3.7 billion, compared to the consensus revenue estimate of $3.7 billion.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on XRAY shares. Piper Sandler lowered their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday, April 30th. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a "hold" rating on the stock in a research note on Friday. Barrington Research set a $18.00 target price on DENTSPLY SIRONA and gave the stock an "outperform" rating in a research note on Friday. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Monday, July 21st. Finally, Morgan Stanley lowered DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research note on Tuesday, April 15th. Twelve investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of "Hold" and a consensus price target of $18.64.

DENTSPLY SIRONA Stock Down 2.4%

Shares of NASDAQ XRAY traded down $0.32 during midday trading on Monday, hitting $12.65. 2,408,720 shares of the company's stock were exchanged, compared to its average volume of 2,973,823. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. DENTSPLY SIRONA has a twelve month low of $12.16 and a twelve month high of $27.48. The company has a market cap of $2.52 billion, a PE ratio of -2.67, a P/E/G ratio of 0.80 and a beta of 0.94. The firm's fifty day simple moving average is $15.71 and its 200-day simple moving average is $15.87.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same quarter last year, the company earned $0.49 EPS. The business's quarterly revenue was down 4.9% on a year-over-year basis. Research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $0.64 annualized dividend and a yield of 5.1%. DENTSPLY SIRONA's payout ratio is -13.50%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in DENTSPLY SIRONA during the first quarter worth approximately $26,000. Empowered Funds LLC increased its position in DENTSPLY SIRONA by 8.8% during the first quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier's stock worth $244,000 after buying an additional 1,320 shares during the period. Focus Partners Wealth increased its holdings in shares of DENTSPLY SIRONA by 59.1% in the first quarter. Focus Partners Wealth now owns 25,181 shares of the medical instruments supplier's stock valued at $376,000 after purchasing an additional 9,355 shares during the period. Cetera Investment Advisers increased its holdings in shares of DENTSPLY SIRONA by 27.5% in the second quarter. Cetera Investment Advisers now owns 27,064 shares of the medical instruments supplier's stock valued at $430,000 after purchasing an additional 5,839 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of DENTSPLY SIRONA by 7.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 593,021 shares of the medical instruments supplier's stock valued at $8,860,000 after purchasing an additional 41,579 shares during the period. Institutional investors and hedge funds own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.